Company news
Poxel Sa (EURONEXT:POXEL) news
Poxel Sa news releases on 6ix. Latest, Oct 1, 2026: Poxel : nombre d’actions et de droits de vote composant le capital social
Press releases & updates
Poxel : nombre d’actions et de droits de vote composant le capital social
September 30, 2026
Laure-Hélène Mercier Co-Opted as Chair of the Board of Directors of Poxel
September 3, 2026
Poxel Publishes Its Turnover for the Second Quarter of 2026 and Announces the Postponement of the Publication of Its 2025 Financial Statements
July 30, 2026
Poxel Appoints Yves Decadt as Chief Executive Officer to Accelerate Portfolio Development and Strategic Partnerships
June 10, 2026
Poxel Reports First Quarter 2026 Revenue and Provides a Business Update
May 20, 2026
Poxel: Postponement of the Publication of the 2025 Annual Financial Statements and the Annual Financial Report
April 30, 2026
Poxel Announces the Sale of PXL770 to Scynexis for a Total Amount of up to $196 Million
March 31, 2026
Poxel Confirms the Drawdown Under the Additional Tranche D PDR Bond Issue as Part of the Continuation Plan
March 25, 2026
Poxel Reports its 2025 Revenue and Provides an Update on its Financial Position
February 16, 2026
Poxel Announces the Implementation of an Equity Line With IRIS Capital as Part of the Execution of the Recovery Plan
February 3, 2026
POXEL SA: The Commercial Court of Lyon Approves the Recovery Plan and Brings an End to the Judicial Reorganisation Proceedings
January 30, 2026
Availability of Poxel’s 2025 Half-Year Financial Report
December 18, 2025
Poxel Announces Results of its Combined General Meeting Held on December 11, 2025
December 11, 2025
Poxel Publishes Its Financial Results for the First Half of 2025
December 10, 2025
POXEL SA: Update on the Proposed Recovery Plan and Organisation of a Webinar
November 24, 2025
Poxel Announces That a Combined General Meeting Will Be Held on December 11, 2025 and the Availability of the Preparatory Documents
November 20, 2025
Poxel Reports Revenue for the Third Quarter 2025
November 13, 2025
POXEL SA: Update on the Draft Recovery Plan and Convening of the Annual General Meeting of Shareholders
November 5, 2025
Appointment of Yves Decadt as Member of Poxel’s Board of Directors
October 31, 2025
Poxel: Availability of the 2024 Universal Registration Document
October 23, 2025
Poxel: Availability of a First Document in Response to Questions Received From Shareholders
October 20, 2025
Poxel Reports Financial Results for Full Year 2024 and Provides Operational and Financial Update
October 16, 2025
Poxel Announces the Availability of a Bond Issue for a Maximum Amount of €2.5 Million
September 29, 2025
Poxel Announces the Opening of Reorganization Proceedings
August 8, 2025
Following the Filing for the Opening of Reorganization Proceedings, Poxel Announces Changes to Its Corporate Governance
August 1, 2025
Poxel Provides Update on Negotiations with Creditors and Announces Filing of Reorganization Proceedings, Upcoming Change of Corporate Governance and Suspension of Trading
July 29, 2025
Poxel Announces Postponement of its Annual General Meeting and Provides a Corporate Update
June 30, 2025
Poxel SA: New Scientific Presentations by Key Opinion Leaders to Further Highlight the Therapeutic Potential of Imeglimin at ADA 2025, the Leading Diabetes Conference
June 19, 2025
New Clinical and Scientific Data on TWYMEEG® to be Presented at the 68th Annual Meeting of the Japan Diabetes Society
May 28, 2025
Poxel Announces Positive Preclinical Data for PXL065 in Hypertrophic Cardiomyopathy To Be Presented at the ESC Congress 2025
May 26, 2025
Poxel Reports Consolidated Revenue for the First Quarter 2025 and Provides Corporate Update
May 13, 2025